Skip to main content
CMND
NASDAQ Life Sciences

Clearmind Medicine 拓展知识产权，在印度提交下一代迷幻化合物专利申请

feedReported by GlobeNewswire
Sentiment info
Positive
Importance info
7
Price
$0.73
Mkt Cap
$1.539M
52W Low
$0.595
52W High
$52.4
Market data snapshot near publication time

summarizeSummary

Clearmind Medicine Inc.宣布在印度提交了一项针对新型下一代基于迷幻的化合物的专利申请，这些化合物旨在治疗心理健康障碍和成瘾。这种举动扩大了公司在全球知识产权投资组合，继本月早些时候在香港提交和发布专利申请之后。对于一家小盘生物科技公司来说，在像印度这样的新管辖区确保知识产权是一个积极的步骤，可能会扩大未来的市场准入并保护其研发投资。交易者将关注专利批准和这些化合物在临床开发中进展的进一步更新。

在该公告发布时，CMND的交易价格为$0.73，交易所为NASDAQ，所属行业为Life Sciences，市值约为$153.9万。 52周交易区间为$0.59至$52.40。 这则新闻被评估为积极市场情绪，重要性评分为7/10。 来源：GlobeNewswire。

show_chartPrice Chart

Share this article

Copied!

feed CMND - Latest Insights

CMND
Apr 27, 2026, 7:45 AM EDT
Filing Type: 6-K
Importance Score:
7
Clearmind Medicine Evaluates Lead Candidate CMND-100 for FDA Breakthrough Therapy Designation
Sentiment: Positive
View Wiseek Article
CMND
Apr 27, 2026, 7:41 AM EDT
Source: GlobeNewswire
Importance Score:
7
Clearmind Medicine Eyes FDA Breakthrough Therapy Designation for CMND-100
Sentiment: Positive
View Wiseek Article
CMND
Apr 21, 2026, 6:57 AM EDT
Filing Type: 6-K
Importance Score:
9
Clearmind Medicine Converts $2.68M in Notes into 4.47M Shares, Causing Significant Dilution
Sentiment: Negative
View Wiseek Article
CMND
Apr 20, 2026, 5:18 PM EDT
Filing Type: 6-K
Importance Score:
9
Clearmind Medicine Secures $2.43M in Highly Dilutive Convertible Note Financing
Sentiment: Negative
View Wiseek Article
CMND
Apr 20, 2026, 4:05 PM EDT
Filing Type: 6-K
Importance Score:
8
Presidential Executive Order Boosts Psychedelic Drug Development, Favors Clearmind's Pipeline
Sentiment: Positive
View Wiseek Article
CMND
Apr 15, 2026, 9:15 AM EDT
Filing Type: 6-K
Importance Score:
8
Clearmind Medicine's CMND-100 Trial Advances to Next Cohort with Increased Dose After Positive DSMB Review
Sentiment: Positive
View Wiseek Article
CMND
Apr 15, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
CMND-100 Trial Receives DSMB Approval to Advance, Increase Dose
Sentiment: Positive
View Wiseek Article
CMND
Apr 15, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Clearmind Medicine Converts $1.75M in Notes at $0.60/Share, Causing Significant Dilution
Sentiment: Negative
View Wiseek Article
CMND
Apr 14, 2026, 4:01 PM EDT
Filing Type: 6-K
Importance Score:
9
Clearmind Medicine Secures $1.575M in Highly Dilutive Convertible Note Financing
Sentiment: Negative
View Wiseek Article
CMND
Apr 14, 2026, 8:23 AM EDT
Filing Type: 6-K
Importance Score:
8
Clearmind Medicine's CMND-100 Meets Primary Endpoint in Phase I/IIa AUD Trial
Sentiment: Positive
View Wiseek Article